Tower Research Capital (TRC)’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1K Buy
1,765
+464
+36% +$3.89K ﹤0.01% 3631
2025
Q4
$9.68K Sell
1,301
-671
-34% -$4.82K ﹤0.01% 3884
2025
Q3
$13.2K Sell
1,972
-3,465
-64% -$24K ﹤0.01% 3712
2025
Q2
$36K Buy
5,437
+2,498
+85% +$17.7K ﹤0.01% 3250
2025
Q1
$26.9K Sell
2,939
-530
-15% -$5.29K ﹤0.01% 2696
2024
Q4
$36.4K Buy
3,469
+1,786
+106% +$21.1K ﹤0.01% 2762
2024
Q3
$20.1K Buy
+1,683
New +$14.6K ﹤0.01% 3235
2024
Q2
Sell
-5,051
Closed -$26.3K 5707
2024
Q1
$26.3K Buy
5,051
+1,438
+40% +$7.03K ﹤0.01% 2761
2023
Q4
$19K Sell
3,613
-19,478
-84% -$77.1K ﹤0.01% 3679
2023
Q3
$76.2K Buy
23,091
+16,878
+272% +$59.2K ﹤0.01% 2195
2023
Q2
$18K Sell
6,213
-5,258
-46% -$10.1K ﹤0.01% 3483
2023
Q1
$12K Buy
11,471
+4,590
+67% +$8.78K ﹤0.01% 4053
2022
Q4
$18K Sell
6,881
-11,555
-63% -$50.5K ﹤0.01% 3204
2022
Q3
$129K Buy
18,436
+4,060
+28% +$31.8K ﹤0.01% 2330
2022
Q2
$98K Buy
14,376
+13,853
+2,649% +$141K ﹤0.01% 2310
2022
Q1
$7K Sell
523
-404
-44% -$5.41K ﹤0.01% 4698
2021
Q4
$13K Buy
927
+246
+36% +$3.5K ﹤0.01% 4153
2021
Q3
$10K Buy
681
+153
+29% +$2.35K ﹤0.01% 4303
2021
Q2
$10K Sell
528
-850
-62% -$13.7K ﹤0.01% 4374
2021
Q1
$21K Buy
+1,378
New +$19.6K ﹤0.01% 3834

Other funds holding BVS